HIT! High Impact Clinical Trials 1
28 Mar 2026 15:45 16:45
Main Hall
| Time | Session |
|---|---|
|
15:45
15:55
|
REMODEL Trial Overview: Framework and Key Outcomes
|
|
15:55
16:05
|
Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial
|
|
16:05
16:15
|
Aldosterone Blockade for Health Improvement Evaluation in End-stage Renal Disease Trial
(ACHIEVE)
|
|
16:15
16:25
|
B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil
|
|
16:25
16:40
|
Q&A Session
|